Optimal Timing for Lithium Level Collection
Lithium levels should be drawn 12 hours after the last dose for patients taking immediate-release formulations, and 24 hours after the last dose for patients taking once-daily extended-release formulations.
Standard Timing for Immediate-Release Lithium
The FDA drug label explicitly states that "blood samples for serum lithium determination should be drawn immediately prior to the next dose when lithium concentrations are relatively stable (i.e., 8-12 hours after the previous dose)" 1. This 12-hour timing represents the established standard against which virtually all published lithium dosing data has been validated 2.
For patients taking lithium in divided doses (twice or three times daily), the 12-hour collection time provides a trough level that accurately reflects steady-state concentrations and correlates reliably with therapeutic efficacy 3.
Modified Timing for Extended-Release Formulations
For patients taking once-daily extended-release lithium preparations, blood should be drawn 24 hours after the last dose 4. This critical distinction exists because:
- Extended-release formulations delay absorption but do not alter elimination kinetics
- At 12 hours post-dose with extended-release preparations, serum levels are approximately 1.3 times higher than true trough levels 4
- Drawing at 12 hours with once-daily dosing would overestimate the actual trough concentration, potentially leading to underdosing 4
- By 24 hours, the measured level represents the true trough before the next dose 3
Clinical Reality: Poor Compliance with Timing
Recent evidence reveals significant problems with timing compliance in clinical practice:
- In a multicenter US trial, 44.9% of lithium levels were drawn outside the 10-14 hour window 5
- In a real-world Danish population study of over 52,000 blood tests, 49.7% were non-compliant with the 12-hour standard 5
- Patients with blood draws >14 hours after dosing had significantly lower measured levels (0.41 vs 0.64 mmol/L), risking inappropriate dose increases 5
Practical Algorithm for Timing
Step 1: Identify the lithium formulation
- Immediate-release (standard lithium carbonate): 12-hour timing
- Extended-release/sustained-release (once-daily): 24-hour timing
Step 2: Verify patient's actual dosing schedule
- Multiple daily doses → 12 hours after last dose
- Single daily dose → 24 hours after last dose (regardless of formulation, though extended-release is typical)
Step 3: Document the actual time between last dose and blood draw
- Patient self-report is notoriously unreliable 5
- Consider using estimation equations if timing is off 6
Common Pitfalls to Avoid
- Assuming all patients take lithium at the same time: Many patients take evening doses, so "morning labs" may not equal 12 hours
- Applying 12-hour timing to once-daily dosing: This systematically overestimates trough levels by 30% 4
- Not documenting actual timing: Without knowing when the patient last took lithium, the level is uninterpretable
- Ignoring non-compliant timing: Levels drawn at incorrect times should not be used to make dosing decisions without adjustment 6
Monitoring Frequency
During acute stabilization: Twice weekly until stable 1
During maintenance: Every 2 months for uncomplicated cases 1, though more frequent monitoring (every 3-6 months) is recommended alongside renal and thyroid function 7
The therapeutic target range is 0.6-1.2 mEq/L for maintenance treatment 1, with lower ranges (0.4-0.8 mmol/L) increasingly recommended for older adults aged 60-79 years 8.